DUBLIN--(BUSINESS WIRE)--The "North America Creatinine Measurement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Type; Sample Type; End-User, and Country" report has been added to ResearchAndMarkets.com's offering.
The North American Creatinine Measurement Market is expected to reach US$ 269.75 million in 2027 from US$ 148.79 million in 2019. The market is estimated to grow with a CAGR of 7.8% from 2020-2027.
The growth of the creatinine measurement market is attributed to the increasing prevalence of chronic kidney disorders, growing geriatric population, and others. In recent years, the developments in the biotechnology sectors have accelerated due to the expansion of technological and engineering applications. The growth in biotechnology industry has enabled launches of various products based on bioengineering concepts.
Thus, innovations have supported the introduction of various technically advanced systems and have enabled to improve healthcare facilities. Thus, technological factors are likely to foster the growth of the North America creatinine measurement market during the forecast period.
Various companies are focusing on the advancement of the Creatinine Measurement market. For instance, Abbott, Danaher, Siemens Healthineers, and Diazyme Laboratories, Inc. have done recent developments for products.
The Jaffe's Kinase method segment held the largest market share in the North American creatinine measurement market, which is attributed to the increasing adoption of this method due to extended range of advantages. Moreover, increasing prevalence of chronic kidney diseases coupled with growing awareness and availability of the product in considerable margins are projected to drive the growth of the segment during the forecast period.
The US registered as the fastest-growing region in the North American creatinine measurement market. The growth of the market in the US is attributed due to rising support from the government, increasing geriatric population, implementation of strategic marketing policies by major players, and increasing incidence of chronic kidney diseases.
Key Topics Covered:
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
2. Creatinine Measurement Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Creatinine Measurement - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Expert Opinion
5. Creatinine Measurement - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Kidney Disorders
5.1.2 Growing Geriatric Population
5.2 Market Restraints
5.2.1 Shift Toward Novel Biomarkers
5.3 Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Point-of-Care Renal Functioning Testing
5.5 Impact Analysis
6. Creatinine Measurement Market - Regional Analysis
6.1 North America Creatinine Measurement Market Revenue Forecast And Analysis
7. Creatinine Measurement Market Analysis - By Product
7.1 Overview
7.2 Creatinine Measurement Market Revenue Share, by Product (2019 and 2027)
7.3 Kits
7.4 Reagents
8. Creatinine Measurement Market - By Type
8.1 Overview
8.2 Creatinine Measurement Market, by Type, 2019 and 2027 (%)
8.3 Enzymatic Method
8.4 Jaffe's Kinetic Method
9. Creatinine Measurement Market - By Sample Type
9.1 Overview
9.2 Creatinine Measurement Market, by Sample Type, 2019 and 2027 (%)
9.3 Blood or Serum
9.4 Urine
10. Creatinine Measurement Market Analysis - By End User
10.1 Overview
10.2 Creatinine Measurement Market, by End User (2019 and 2027)
10.3 Hospitals
10.4 Diagnostic Laboratories
10.5 Others
11. Creatinine Measurement Market - Regional Analysis
12. Creatinine Measurement Market- Industry Landscape
13. Creatinine Measurement Market - Key Company Profiles
- Abbott
- Beijing Jiuqiang Biotechnology Co., Ltd.
- Beijing Leadman Biochemical Co., Ltd.
- Cayman Chemical
- Danaher
- Dialab GmbH
- Diazyme Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Fujifilm Wako Pure Chemical Corporation
- Randox Laboratories Ltd
- Shanghai Fosun Pharmaceutical Group Co., Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/uw8syp.
